1. Home
  2. SGMT vs AENT Comparison

SGMT vs AENT Comparison

Compare SGMT & AENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • AENT
  • Stock Information
  • Founded
  • SGMT 2006
  • AENT 1990
  • Country
  • SGMT United States
  • AENT United States
  • Employees
  • SGMT N/A
  • AENT N/A
  • Industry
  • SGMT
  • AENT Durable Goods
  • Sector
  • SGMT
  • AENT Consumer Discretionary
  • Exchange
  • SGMT Nasdaq
  • AENT Nasdaq
  • Market Cap
  • SGMT 230.3M
  • AENT 254.3M
  • IPO Year
  • SGMT 2023
  • AENT N/A
  • Fundamental
  • Price
  • SGMT $6.15
  • AENT $6.80
  • Analyst Decision
  • SGMT Strong Buy
  • AENT Strong Buy
  • Analyst Count
  • SGMT 7
  • AENT 1
  • Target Price
  • SGMT $26.57
  • AENT $10.00
  • AVG Volume (30 Days)
  • SGMT 461.6K
  • AENT 85.7K
  • Earning Date
  • SGMT 11-12-2025
  • AENT 09-10-2025
  • Dividend Yield
  • SGMT N/A
  • AENT N/A
  • EPS Growth
  • SGMT N/A
  • AENT 228.78
  • EPS
  • SGMT N/A
  • AENT 0.30
  • Revenue
  • SGMT N/A
  • AENT $1,063,457,000.00
  • Revenue This Year
  • SGMT N/A
  • AENT $4.85
  • Revenue Next Year
  • SGMT N/A
  • AENT N/A
  • P/E Ratio
  • SGMT N/A
  • AENT $23.83
  • Revenue Growth
  • SGMT N/A
  • AENT N/A
  • 52 Week Low
  • SGMT $1.73
  • AENT $1.68
  • 52 Week High
  • SGMT $11.41
  • AENT $11.57
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 30.58
  • AENT 59.67
  • Support Level
  • SGMT $6.77
  • AENT $5.03
  • Resistance Level
  • SGMT $7.35
  • AENT $7.54
  • Average True Range (ATR)
  • SGMT 0.41
  • AENT 0.70
  • MACD
  • SGMT -0.07
  • AENT 0.11
  • Stochastic Oscillator
  • SGMT 5.57
  • AENT 70.75

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

About AENT Alliance Entertainment Holding Corporation

Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.

Share on Social Networks: